Most Read Articles
26 Jun 2020

Achieving standard of care targets, such as reduced levels of low-density lipoprotein cholesterol and glycated haemoglobin, improves outcomes in coronary heart disease patients, a new study has found.

Pearl Toh, 19 Jan 2018
Blood pressure (BP) control can be best achieved with a multilevel, multicomponent approach involving team-based care with physician- and non-physician-led interventions, as well as patient-level strategies, according to findings of a meta-analysis.
Dr. Joseph Delano Fule Robles, 24 Jul 2018

Functional foods benefit the body beyond its nutritional effects, with studies showing that they can improve general state of health and reduce the risk of diseases.

29 Mar 2020
Targeting a low-density lipoprotein cholesterol level <70 mg/dL following an ischaemic stroke of atherosclerotic origin helps to avoid one in four subsequent major vascular events without increasing the risk of intracranial haemorrhage over about 5 years of follow-up, according to data from the Treat Stroke to Target trial.

Glucagon tied to higher risk of ischaemic heart disease

18 Jun 2020

Glucagon appears to have a negative effect on ischaemic heart disease, suggests a study.

“Glucagon acts reciprocally with insulin to regular blood glucose,” the investigators said. “However, the effect of glucagon on cardiovascular disease has not been widely studied.”

This two-sample Mendelian randomization study sought to determine whether glucagon, the main counteracting hormone of insulin, plays a role in the development of ischaemic heart disease.

The investigators used the inverse-variance weighted method with multiplicative random effects and multiple sensitivity analyses to estimate the causal effect of glucagon on ischaemic heart disease as well as its risk factors. They obtained genetic associations with glucagon and ischaemic heart disease and its risk factors, including type 2 diabetes and fasting insulin, from publicly available genome-wide association studies.

A total of 24 single-nucleotide polymorphisms that were strongly (p<5x10-6) and independently (r2<0.05) predictive of glucagon were identified.

Genetically predicted higher glucagon was found to correlate with a higher risk of ischaemic heart disease (inverse-variance weighted odds ratio [OR], 1.03, 95 percent confidence interval [CI], 1.0003–1.05) but not with type 2 diabetes (inverse-variance weighted OR, 0.998, 95 percent CI, 0.97–1.03), log-transformed fasting insulin (inverse-variance weighted beta, 0.002, 95 percent CI, –0.01 to 0.01), other glycaemic traits, blood pressure, reticulocyte, or lipids.

“Relevance of the underlying pathway to existing and potential interventions should be investigated,” the investigators said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
26 Jun 2020

Achieving standard of care targets, such as reduced levels of low-density lipoprotein cholesterol and glycated haemoglobin, improves outcomes in coronary heart disease patients, a new study has found.

Pearl Toh, 19 Jan 2018
Blood pressure (BP) control can be best achieved with a multilevel, multicomponent approach involving team-based care with physician- and non-physician-led interventions, as well as patient-level strategies, according to findings of a meta-analysis.
Dr. Joseph Delano Fule Robles, 24 Jul 2018

Functional foods benefit the body beyond its nutritional effects, with studies showing that they can improve general state of health and reduce the risk of diseases.

29 Mar 2020
Targeting a low-density lipoprotein cholesterol level <70 mg/dL following an ischaemic stroke of atherosclerotic origin helps to avoid one in four subsequent major vascular events without increasing the risk of intracranial haemorrhage over about 5 years of follow-up, according to data from the Treat Stroke to Target trial.